Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sanofi India Limited ( (IN:SANOFI) ) just unveiled an announcement.
Sanofi India Limited has announced a key change in its management team, with Mr. Arjun Thakkar resigning as the Company Secretary and Compliance Officer, effective 30th September 2025, to take on another role within the Sanofi group. Mr. Haresh Vala has been appointed as his successor, effective 1st October 2025, and will also serve as a Key Managerial Personnel and Senior Management Personnel. This transition is significant for the company as it continues to align its leadership structure with its strategic objectives, ensuring compliance and effective communication with stock exchanges.
More about Sanofi India Limited
Sanofi India Limited operates in the pharmaceutical industry, focusing on the development and distribution of healthcare products. The company is part of the global Sanofi group, which is known for its extensive range of pharmaceutical solutions.
Average Trading Volume: 699
Technical Sentiment Signal: Hold
Current Market Cap: 114.9B INR
For an in-depth examination of SANOFI stock, go to TipRanks’ Overview page.